ACRO BIOMEDICAL CO., LTD.
Close on Oct 19, 2026
- Market cap
- $1.56M
- P/E (TTM)
- –
- Dividend yield
- –
About Acro Biomedical
Services-Amusement & Recreation Services, SIC 7900
Acro Biomedical Co., Ltd., formerly known as Killer Waves Hawaii, Inc., develops and markets nutritional wellness products centered on cordyceps, a parasitic fungus traditionally utilized in Chinese medicine. Historically, the company has purchased inventory from suppliers in Taiwan to sell in bulk to commercial customers, including distributors. These clients either resell the products directly or incorporate them as ingredients into finished goods. The company has also previously sold metallothionein MT-3 elizer and explored developing cordyceps-based chicken feed, though it does not package or offer items directly for retail consumer use.
The enterprise operates as a Nevada corporation with its corporate office located in Fishers, Indiana. It maintains an extremely limited operational scale, employing a single part-time executive and owning no retail stores, dedicated manufacturing facilities, or intellectual property rights. Its past commercial transactions and customer relationships were centered internationally in Taiwan and Hong Kong, with no historical product sales conducted within the United States.
Summary of the business section of Acro Biomedical's latest annual report, written by StockData.
Company profile
Company
- Legal name
- ACRO BIOMEDICAL CO., LTD.
- Founded
- 2014
- Headquarters
- Fishers, IN
- Address
- 12175 Visionary Way, Suite 1160 46038
- Phone
- (317) 286-6788
- Website
- acrobiomedicalco.com
- Employees
- 1, Dec 31, 2025
- Industry
- Services-Amusement & Recreation Services
- Incorporated in
- Nevada
- Fiscal year ends
- December 31
- Auditor
- Weinberg & Company, P.A., Los Angeles, California
Stock & identifiers
- Ticker
- ACBM
- Exchange
- OTC
- IPO date
- Apr 12, 2018
- Shares outstanding
- 60M, Aug 5, 2026
- Public float
- $21.03K, Jun 30, 2025
- Filer category
- Non-accelerated filer<br>Smaller reporting company
- Stock splits
- 3-for-1, May 18, 2017
- SEC CIK
- 1622996
- EIN
- 47-1950356
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
No recent ownership filings by officers or directors
Acro Biomedical's leadership is listed in its proxy statement (Form DEF 14A).
Employees
Headcount reported in annual reports
“We have one employee, our chief executive officer and chief financial officer, who works for us on a part-time basis.”
Corporate history
Events identified from SEC filings